BTAI - BioXcel Therapeutics Inc. (BTAI) Q1 2024 Earnings Call Transcript

2024-05-09 09:53:09 ET

BioXcel Therapeutics, Inc. (BTAI)

Q1 2024 Results Earnings Conference Call

May 9, 2024, 08:00 AM ET

Company Participants

Vimal Mehta - Chief Executive Officer and Founder

Vincent O'Neill - Executive Vice President and Chief of Product Development and Medical Officer

Richard Steinhart - Senior Vice President and Chief Financial Officer

Matt Wiley - Senior Vice President and Chief Commercial Officer

Robert Risinger - Chief Medical Officer, Neuroscience

Conference Call Participants

Colin Bristow - UBS

Ram Selvaraju - H.C. Wainwright

Alec Stranahan - Bank of America

Avantika Joshi - Mizuho Securities

Sumant Kulkarni - Canaccord Genuity

Samir Devani - Rx Securities

Presentation

Operator

Good morning. And welcome to the BioXcel Therapeutics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions].

Just to remind everyone, certain matters discussed in today's conference call and/or answers that may be given to questions asked are forward-looking statements subject to risks and uncertainties related to future events and/or the future financial or business performance of the company. Actual results could differ materially from those anticipated in those forward-looking statements....

For further details see: